PASSION FOR IDEAS

Axovan

Founded in April 2000. Discovery and development of small molecules active on novel G protein-coupled receptors. CHF38 Mio raised, 60 employees. Most advanced project (Phase II): sub-arachnoid haemorrhage. Acquired by Actelion (ATLN) in October 2003.


Recent News


Company Info
 
Country: Switzerland
Industry:    LS
Sector: biotechnology
Status: Realized
Vehicle: Genevest


Key persons
 Olivier Valdenaire, co-Founder & CEO; Philippe Dro, CFO; Thomas Giller: co-Founder & CSO; Rudolf Maag, Chairman


Company website
 www.actelion.com


Endeavour Vision Team
 
Sven Lingjaerde
partner of the European Tech Tour "The partners have been very supportive of our approach and stepped in to add value when needed. I would strongly recommend them as investors."
Didier Cowling, Founder and CEO, Kuros Biosurgery AG